Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Guidelines for testosterone therapy for men: how to avoid a mad (t)ea party by getting personal.

× No keyword cloud information.

20 in total

1. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial.

Authors: Ian M Thompson; Donna Pauler Ankerst; Chen Chi; Phyllis J Goodman; Catherine M Tangen; M Scott Lucia; Ziding Feng; Howard L Parnes; Charles A Coltman
Journal: J Natl Cancer Inst Date: 2006-04-19 Impact factor: 13.506

2. Persistent intraprostatic androgen concentrations after medical castration in healthy men.

Authors: Stephanie T Page; Daniel W Lin; Elahe A Mostaghel; David L Hess; Lawrence D True; John K Amory; Peter S Nelson; Alvin M Matsumoto; William J Bremner
Journal: J Clin Endocrinol Metab Date: 2006-08-01 Impact factor: 5.958

3. Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study.

Authors: Kay-Tee Khaw; Mitch Dowsett; Elizabeth Folkerd; Sheila Bingham; Nicholas Wareham; Robert Luben; Ailsa Welch; Nicholas Day
Journal: Circulation Date: 2007-11-26 Impact factor: 29.690

4. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.

Authors:
Journal: Ann Intern Med Date: 2008-08-05 Impact factor: 25.391

5. Commentary on "prostate cancer screening in the randomized prostate, lung, colorectal, and ovarian cancer screening trial: Mortality results after 13 years of follow-up". Andriole GL, Crawford ED, Grubb RL III, Buys SS, Chia D, Church TR, Fouad MN, Isaacs C, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Ragard LR, Clapp JD, Rathmell JM, Riley TL, Hsing AW, Izmirlian G, Pinsky PF, Kramer BS, Miller AB, Gohagan JK, Prorok PC; PLCO Project Team.Collaborators (18) Buring JE, Alberts D, Carter HB, Chodak G, Hawk E, Malm H, Mayer RJ, Piantadosi S, Silvestri GA, Thompson IM, Westhoff CL, Kahn JP, Levin B, DeMets D, O'Fallon JR, Porter AT, Ashton MM, Black WC, Division of Urologic Surgery, Washington University School of Medicine, St. Louis, MO 63130, USA: J. Natl Cancer Inst 2012; 104(2):125-32. Epub January 6, 2012.

Authors: Joseph A Smith
Journal: Urol Oncol Date: 2012 Nov-Dec Impact factor: 3.498

6. Endogenous sex hormones and cardiovascular disease incidence in men.

Authors: Johan Arnlöv; Michael J Pencina; Shreyasee Amin; Byung-Ho Nam; Emelia J Benjamin; Joanne M Murabito; Thomas J Wang; Philip E Knapp; Ralph B D'Agostino; Shalendar Bhasin; Ramachandran S Vasan
Journal: Ann Intern Med Date: 2006-08-01 Impact factor: 25.391

7. Adverse events associated with testosterone replacement in middle-aged and older men: a meta-analysis of randomized, placebo-controlled trials.

Authors: Olga M Calof; Atam B Singh; Martin L Lee; Anne M Kenny; Randall J Urban; Joyce L Tenover; Shalender Bhasin
Journal: J Gerontol A Biol Sci Med Sci Date: 2005-11 Impact factor: 6.053

8. Performance of prostate cancer prevention trial risk calculator in a contemporary cohort screened for prostate cancer and diagnosed by extended prostate biopsy.

Authors: Carvell T Nguyen; Changhong Yu; Ayman Moussa; Michael W Kattan; J Stephen Jones
Journal: J Urol Date: 2009-12-14 Impact factor: 7.450

Review 9. Androgens and cardiovascular disease.

Authors: Peter Y Liu; Alison K Death; David J Handelsman
Journal: Endocr Rev Date: 2003-06 Impact factor: 19.871

10. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors: Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal: JAMA Date: 2002-07-17 Impact factor: 56.272

3 in total

Review 1. Hormone replacement therapy and physical function in healthy older men. Time to talk hormones?

Authors: Manthos G Giannoulis; Finbarr C Martin; K Sreekumaran Nair; A Margot Umpleby; Peter Sonksen
Journal: Endocr Rev Date: 2012-03-20 Impact factor: 19.871

2. Dose-Response Relationships Between Gonadal Steroids and Bone, Body Composition, and Sexual Function in Aging Men.

Authors: Joel S Finkelstein; Hang Lee; Sherri-Ann M Burnett-Bowie; Karin Darakananda; Emily C Gentile; David W Goldstein; Sarah H Prizand; Laura M Krivicich; Alexander P Taylor; Kendra E Wulczyn; Benjamin Z Leder; Elaine W Yu
Journal: J Clin Endocrinol Metab Date: 2020-08-01 Impact factor: 5.958

3. Four Thrombotic Events Over 5 Years, Two Pulmonary Emboli and Two Deep Venous Thrombosis, When Testosterone-HCG Therapy Was Continued Despite Concurrent Anticoagulation in a 55-Year-Old Man With Lupus Anticoagulant.

Authors: Charles J Glueck; Kevin Lee; Marloe Prince; Vybhav Jetty; Parth Shah; Ping Wang
Journal: J Investig Med High Impact Case Rep Date: 2016-08-01

3 in total